Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
Category: Respiratory Disease
Respiratory Disease
Latest
Respiratory Disease
Latest
Sapphiros Awarded $11M to Develop Over-the-Counter Respiratory Test
Sapphiros was selected by the NIH RADx Tech program to develop an over-the-counter, molecular multiplex respiratory diagnostic test.
Respiratory Disease
Latest
Ellume’s New Tuberculosis Test Approved for Use in Low-Resource Countries
Tech to advance the control of tuberculosis in areas with limited infrastructure has been approved by the Global Fund's Expert Review Panel for Diagnostics.Â
Urine Test Could Help Assess Aspects of Cystic Fibrosis
New research provides insights on the effects of cystic fibrosis in the kidneys, pointing to the potential for a urine test related to the disease.
Read MoreNew At-Home Test Combines Covid-19, Influenza, and a 21-Test Respiratory Panel
The home saliva test also includes adenovirus, other coronaviruses, rhinovirus, parainfluenzas, pneumoniae, and other respiratory conditions.
Read More
Exact Diagnostics Launches Multiplex Control for Use with Molecular Respiratory Panel Assays
Routine use of the positive run control enables laboratories to meet their individualized quality control goals, including evaluation of reagent lot changes and new shipments.
Read More
Thermo Fisher, NanoPin Collaborate to Develop Analytical Workflow for Infectious Disease Diagnosis and Patient Monitoring
NanoPin’s diagnostic platform using Thermo Fisher’s advanced LC-MS technology will create sensitive clinical assays for infectious disease.
Read MorePulmonary Fibrosis Foundation Launches Industry Consortium to Identify Biomarkers in Pulmonary Fibrosis
The Pulmonary Fibrosis Foundation has announced a new collaboration that could speed up the development of targeted treatments for individuals with idiopathic pulmonary fibrosis.
Read More
Exact Diagnostics Launches Control for Molecular-Based Respiratory Panel Tests
Routine use of the EDX RP positive run control enables laboratories to meet the requirements of their individualized quality control plans, including evaluation of reagent lot changes and new shipments.
Read More
FDA Clears Applied BioCode Respiratory Pathogen Panel
The panel tests nasopharyngeal swabs for the most common respiratory viruses and bacteria.
Read More
FDA Approves QuantiFeron-TB Gold Plus Test for Liaison Platforms
The test enables highly automated screening for latent tuberculosis.
Read More
Mologic Launches Clinical Trial to Identify Early Signs of COPD
The Headstart system is designed for home monitoring and integrates a simple, easy-to-use diagnostic with a reader and mobile phone app to capture patient-specific health data.
Read More
Cost-Effective Tests for Lyme Disease and TBRF
IGeneX’s new BCA assays are simple and cost-effective tests that give either a positive or negative result for exposure to Borrelia spp.
Read More
Owlstone Medical Provides Breath Biopsy Analysis to Study of Immune-Mediated Diseases
The company will receive funding to provide the breath biopsy component of a research initiative designed to provide new insights into the mechanisms of response and nonresponse to treatment for seven immune-mediated diseases.
Read More
Molecular QC for Rifampicin-Resistant Mycobacterium Tuberculosis
Positive and negative controls are designed to help laboratories deliver reliable MTB-RIF testing results.
Read MoreLophius Biosciences Closes $3.4 Million Financing Round for TB Detection Assay
The funding will enable Lophius to expand clinical performance data and finalize design of the assay for use on automated platforms.
Read More
Self-Monitoring Solution in Mobile App Can Help Patients Manage Uncontrolled Asthma
A study by Karolinska Institute researchers shows that an algorithm used in a mobile phone app can efficiently manage uncontrolled asthma.
Read More
New Biomarker May Uncover Uncontrolled Asthma
Study subjects with uncontrolled asthma had substantially higher levels of local IL-26 in their airways, when compared with subjects with controlled asthma.
Read More